3379.0 HIV/AIDS and Hepatitis in Substance Use Settings

Monday, November 8, 2010: 4:30 PM - 6:00 PM
Oral
HIV and hepatitis C are common among injection drug abusers. Substance abuse treatment programs represent a focal point for dealing with all of these medical problems. This session will detail availability of HIV and hepatitis C healthcare services at substance abuse treatment programs, and other issues related to the intersection of substance abuse and infection.
Session Objectives: Describe the interactions between substance abuse and HIV disease Describe the interactions between substance abuse and hepatitis C
Moderator:
Kathye Gorosh, MBA
Panelists:
Lawrence S. Brown, MD, MPH, FASAM , Amy B. Jessop, PhD, MPH , Rashmi Singh, MD and Ana Hilde, MPH

4:30pm
HIV/AIDS-related health services in substance abuse treatment programs
Lawrence S. Brown, MD, MPH, FASAM, Steven Kritz, MD, Edmund J. Bini, MD, MPH, James Robinson, MEd and John Rotrosen, MD
     
4:50pm
Viral hepatitis screening policies and practices in methadone maintenance centers
Amy B. Jessop, PhD, MPH and Amy Micheli, MPH
5:10pm
Factors Associated with the Presence of Isolated Antibody to Hepatitis B Core Antigen (anti-HBc) and Hepatitis C Antibody (HCV) among Drug Users in Methadone Maintenance
Rashmi Singh, MD, Carmen Masson, PhD, Christopher Young, BS BA, Courtney McKnight, MPH, Randy Seewald, MD, Mandana Khalili, Nicholas Hengl, Ashly E. Jordan, BA, Patricia Friedman, PhD, Albert Min, MD, Don C. Des Jarlais, PhD and David C. Perlman, MD
  

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: HIV/AIDS, Women's Caucus

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: Alcohol, Tobacco, and Other Drugs
<< Previous Session | Next Session >>